SCHEMBL7552900

SCHEMBL7552900

NCC(=O)CCCCC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.50
LMNA P02545 5/20 0.41
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 6/20 0.38
CYP1A2 P05177 3/20 0.38
MEN1 O00255 2/20 0.38
SOAT1 P35610 2/20 0.38
TP53 P04637 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
FAAH O00519 1/20 0.38
CYP2D6 P10635 1/20 0.38
NFKB1 P19838 1/20 0.38
HTR2C P28335 1/20 0.36
BLM P54132 4/20 0.36
ALOX15 P16050 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 2/20 0.36
THRB P10828 2/20 0.36
RECQL P46063 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3309093 0.97 GABRR1 (0.48) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL5965334 0.97 GABRR1 (0.48) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL7446931 0.97 GABRR1 (0.48) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL5965326 0.97 GABRR1 (0.48) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL7453042 0.97 GABRR1 (0.48) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL23772898 0.94 GABRR1 (0.50) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL16853135 0.91 GABRR1 (0.58) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL16853370 0.88 GABRR1 (0.55) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL16853123 0.88 GABRR1 (0.55) GABRR1LMNAKDM4EKMT2ACYP1A2
SCHEMBL16853138 0.88 GABRR1 (0.55) GABRR1LMNAKDM4EKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161048-A1 Glycine substitutes and precursors for treating a psychosis GLYTECH, INC. 2002-10-31 US disclosed
US-6355681-B2 ADMINISTERING TO HUMAN A SUBSTITUTE FOR GLYCINE AT THE GLYCINE-SITE OR A PRECURSOR OF SUBSTITUTE OR A GLYCINE PRECURSOR, IN AN AMOUNT SUFFICIENT TO POTENTIATE NMDA RECEPTOR-MEDIATED NEUROTRANSMISSION GLYTECH, INC. 2002-03-12 US disclosed
US-20020013364-A1 GLYCINE SITE FULL AGONIST FOR TREATING A PSYCHOSIS GLYTECH, INC. 2002-01-31 US disclosed